Event

European American Chamber of Commerce Program: How AI is Driving the Future of Life Sciences Markets

April 29, 2026

Partner Maya Elbert and Associate Bojana Bilankov will attend the European American Chamber of Commerce’s Program, “How AI is Driving the Future of Life Sciences Markets.” Life sciences companies are using AI to speed up drug discovery, accelerate commercialization timelines, and improve back-office functions. The strong AI market in the U.S. has allowed for collaborations between AI-focused tech companies, life sciences companies, and universities. However, limitations around centralized data availability have made for challenges with deploying technology for clinical and commercial purposes. Europe has unique advantages due to many countries having centralized health data stores, collaborative networks, and strong public funding for research. As there is an increased investment for companies utilizing AI to improve patient outcomes, life sciences companies who can unlock cross-border collaborations in the AI space may have an edge to tap into capital markets.